We are live on ! Find out more
AP

Antipodes Partners Portfolio holdings

AUM $5.46B
1-Year Est. Return 26.64%
This Fund
S&P 500
This Quarter Est. Return
+5.97%
1 Year Est. Return
+26.64%
3 Year Est. Return
+96.4%
5 Year Est. Return
+160.76%
10 Year Est. Return
–
AUM
$4.76B
AUM Growth
+$305M
Cap. Flow
+$53.3M
Cap. Flow %
1.12%
Top 10 Hldgs %
37.47%
Holding
149
New
33
Increased
46
Reduced
42
Closed
19

Top Buys

Rank Stock Value
1
META icon
Meta Platforms (Facebook)
META
+$120M
2
TTE icon
TotalEnergies
TTE
+$87.9M
3
AMZN icon
Amazon
AMZN
+$68.8M
4
MSFT icon
Microsoft
MSFT
+$58.4M
5
ORCL icon
Oracle
ORCL
+$57.1M

Top Sells

Rank Stock Value
1
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$153M
2
AMD icon
Advanced Micro Devices
AMD
+$90.6M
3
JCI icon
Johnson Controls International
JCI
+$82.5M
4
ALC icon
Alcon
ALC
+$48.2M
5
B
Barrick Mining
B
+$43.2M

Sector Composition

Rank Sector Weight
1 Utilities 25.97%
2 Technology 13.9%
3 Healthcare 12.33%
4 Financials 8.66%
5 Consumer Discretionary 8.35%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
WAT icon
101
Waters Corp
WAT
$40.4B
$66.5K ﹤0.01%
175
+87
+99% +$32K
TEVA icon
102
Teva Pharmaceuticals
TEVA
$42.1B
$65.1K ﹤0.01%
+2,086
New +$51.4K
VRTX icon
103
Vertex Pharmaceuticals
VRTX
$133B
$57.6K ﹤0.01%
+127
New +$54.7K
DXCM icon
104
DexCom
DXCM
$33.1B
$57K ﹤0.01%
858
-759
-47% -$49.1K
FOLD
105
DELISTED
Amicus Therapeutics
FOLD
$55.9K ﹤0.01%
3,926
– –
APGE icon
106
Apogee Therapeutics
APGE
$10.2B
$54.6K ﹤0.01%
723
-120
-14% -$7.56K
NOVT icon
107
Novanta
NOVT
$6.2B
$53.4K ﹤0.01%
+449
New +$51.1K
GE icon
108
GE Aerospace
GE
$380B
$43.4K ﹤0.01%
141
+4
+3% +$1.2K
TNGX icon
109
Tango Therapeutics
TNGX
$4.5B
$40K ﹤0.01%
+4,513
New +$38.9K
IR icon
110
Ingersoll Rand
IR
$33.6B
$39.8K ﹤0.01%
502
+16
+3% +$1.26K
IDYA icon
111
IDEAYA Biosciences
IDYA
$3.54B
$39.8K ﹤0.01%
1,150
+380
+49% +$12.1K
NUVL
112
DELISTED
Nuvalent
NUVL
$39.3K ﹤0.01%
391
– –
CABA icon
113
Cabaletta Bio
CABA
$455M
$37.6K ﹤0.01%
+17,187
New +$42.6K
VRDN icon
114
Viridian Therapeutics
VRDN
$2.61B
$35.8K ﹤0.01%
+1,150
New +$31.5K
IRTC icon
115
iRhythm Holdings
IRTC
$4.1B
$33.5K ﹤0.01%
189
-31
-14% -$5.49K
IRON icon
116
Disc Medicine
IRON
$3.01B
$33.3K ﹤0.01%
+419
New +$35.4K
GPCR icon
117
PUT
Structure Therapeutics
GPCR
$3.83B
$30K ﹤0.01%
+48
New +$1.96K
SIBN icon
118
SI-BONE Inc
SIBN
$845M
$29K ﹤0.01%
+1,470
New +$25.5K
ATAI icon
119
AtaiBeckley Inc
ATAI
$2.68B
$29K ﹤0.01%
+7,081
New +$33.4K
MASS icon
120
908 Devices
MASS
$361M
$26.7K ﹤0.01%
5,094
-133
-3% -$929
DAWN
121
DELISTED
Day One Biopharmaceuticals
DAWN
$23.9K ﹤0.01%
2,559
+828
+48% +$6.92K
ORIC icon
122
Oric Pharmaceuticals
ORIC
$1.41B
$19.6K ﹤0.01%
2,399
-502
-17% -$5.78K
CERT icon
123
Certara
CERT
$1.23B
$19.3K ﹤0.01%
2,190
-10,095
-82% -$104K
DNTH icon
124
Dianthus Therapeutics
DNTH
$6.25B
$18.9K ﹤0.01%
+459
New +$17.8K
SGMT icon
125
Sagimet Biosciences
SGMT
$592M
$18.8K ﹤0.01%
3,176
– –
2 3 4
5
6

Similar funds

DWA
Douglass Winthrop Advisors New York $5.46B AUM 11.49% 1-Year Est. Return
SC
Sessa Capital New York $5.51B AUM 47.23% 1-Year Est. Return
LP
Linonia Partnership New York $5.38B AUM 20.54% 1-Year Est. Return
AS
Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return
DSC
Donald Smith & Co New York $5.56B AUM 47.13% 1-Year Est. Return
KKRC
Kohlberg Kravis Roberts & Co New York $5.35B AUM 63.01% 1-Year Est. Return
WL
WIT LLC District Of Columbia, District of Columbia $5.3B AUM 20.46% 1-Year Est. Return
CRC
Curi RMB Capital Chicago, Illinois $5.62B AUM 18.93% 1-Year Est. Return

Antipodes Partners's Q4 2025 Portfolio in Review

As of Q4 2025, Antipodes Partners held 149 positions worth $4.76B, up 6.8% from $4.46B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Antipodes Partners's Q4 2025 filing shows 33 new, 46 increased, 42 reduced and 19 closed positions. Its largest new stake was Meta Platforms (Facebook): 179,243 shares worth $118M. The largest sale was Alphabet (Google) Class A, an estimated $153M.

By sector, the portfolio is most concentrated in Utilities at 26% of assets, down from 29% a quarter earlier, followed by Technology and Healthcare.

  • Antipodes Partners's largest Q4 2025 buy was Meta Platforms (Facebook): 179,243 shares worth $118M.
  • Antipodes Partners added most to Amazon in Q4 2025, an estimated $68.8M increase.
  • Antipodes Partners's biggest Q4 2025 reduction was Advanced Micro Devices, cutting an estimated $90.6M.
  • Antipodes Partners fully exited Alphabet (Google) Class A in Q4 2025, selling an estimated $153M.
  • Antipodes Partners's ten largest holdings make up 37% of its $4.76B portfolio in Q4 2025.
  • Antipodes Partners opened 33 new positions and closed 19 in Q4 2025.
  • Antipodes Partners's portfolio value rose 6.8% quarter-over-quarter to $4.76B.

Based on Antipodes Partners's 13F filing for Q4 2025, filed 5 Feb 2026.